Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 5mg | $29.00 | $5.80/mg | In stock | Jul 7 |
| vial | 10mg | $49.00 | $4.90/mg | In stock | Jul 7 |
| vial | 30mg | $139.00 | $4.63/mg | In stock | Jul 7 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. CJC-1295 is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Ion Peptide sell CJC-1295?
Yes — Ion Peptide currently lists CJC-1295 in 3 variants starting at $139.00 ($4.63/mg).
Is Ion Peptide's CJC-1295 third-party tested?
Yes — Disclosed Labs has indexed 12 Certificates of Analysis for Ion Peptide's CJC-1295, with the most recent showing 99.6% purity. Ion Peptide holds an overall trust grade of A (92/100) across all 560 COAs on file.
What is Ion Peptide's trust grade for CJC-1295?
Ion Peptide has an overall Disclosed Labs trust grade of A (92/100), computed from 560 COAs across all peptides. The most recent CJC-1295 COA was issued by ILS Labs.
Where is the cheapest CJC-1295?
As of the latest data, Peptide Supply Co. offers CJC-1295 at $3.80/mg — compare with Ion Peptide's listing at $4.63/mg. See the full CJC-1295 price comparison.
Is CJC-1295 legal to buy?
CJC-1295 is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| Unverified1 flag |
| View |
| CJC-30-001 | May 2026 | — | ILS Labs | Endotoxin, Sterility, Heavy metals | Unverified1 flag | View |
| CD5-05042026 | May 2026 | — | ILS Labs | Endotoxin, Sterility, Heavy metals | Unverified1 flag | View |
| CD5-04022026 | Apr 2026 | 100.0% | Kovera Labs | Endotoxin, Sterility, Heavy metals | Confirmed | View |
| CND10-03192026 | Mar 2026 | 100.0% | Kovera Labs | Endotoxin, Sterility, Heavy metals | Confirmed | View |
| CND5-011226 | Jan 2026 | 98.9% | Freedom Diagnostics | — | Confirmed | View |
| CND10-122925 | Dec 2025 | 99.6% | Freedom Diagnostics | — | Confirmed | View |
| CND10-123025 | Dec 2025 | 99.7% | Freedom Diagnostics | — | Confirmed | View |
| CJ10-1025 | Oct 2025 | 99.9% | Freedom Diagnostics | — | Confirmed | View |
| CJ5-1025 | Oct 2025 | 99.5% | Freedom Diagnostics | — | Confirmed | View |
| — | — | 99.5% | Analytical Formulations, Inc. | — | Unverified | View |